Stock Analiz

Bon Natural Life Ltd BON

Medicinal Chemicals and Botanical Products · IPO 2021 · data as of November 13, 2026

$1.10Market cap $9M
Open the interactive analysis →

Bon Natural Life Ltd (BON) is a healthcare company listed in the US with a market value of about $9M. In fiscal year 2025 it had revenue of $19M and net income of -$2M, a net margin of -10.7%.

Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is financial health (3/5); the weakest is value (0/5).

Key numbers: a price to free cash flow of 66.6, 5-year revenue growth of 0% a year, a 5-year average ROIC of 9%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 88% below the current price.

About Bon Natural Life

Bon Natural Life is listed in the US and classified in medicinal chemicals and botanical products, IPO year 2021. Revenue went from $16M in 2019 to $19M in 2025, growth of about 2.2% a year. It was profitable in 6 of the last 7 years in our data. It spends 4% of revenue on research and development.

Score: 0.6 / 5

Value0/5
Future growth0/5
Track record0/5
Financial health3/5
Shareholder returns0/5

Checks passed

  • More cash than debt, or low debt to equity
  • Positive free cash flow
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF66.6
P/S0.5
P/B0.2
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield1.5%
Shareholder yield0.0%
Intrinsic value vs. price−88%

Growth and quality

Revenue growth (1 yr)-21.7%
Revenue growth (5 yrs, per year)0.5%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)9.1%
ROIC (5-yr avg.)9.2%
Profitable years (of last 10)6
Years paying a dividend—

Financials, last 7 years

Fiscal year2025202420232022202120202019
Revenue$19M$24M$30M$30M$25M$18M$16M
Net income-$2M$398172$5M$6M$5M$3M$3M
Free cash flow$134288-$8M-$678810-$214816$4M$3M$7M
EPS (diluted)$-0.25$0.05$0.57$0.77$0.56$0.37$0.32
Net margin-10.7%1.7%15.6%20.9%18.0%16.6%15.7%
ROIC-2.1%2.1%13.1%16.9%15.9%20.4%37.5%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Bon Natural Life stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 88% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Bon Natural Life pay a dividend?

Not currently.

Is Bon Natural Life a good stock to buy?

We do not give buy or sell advice. Bon Natural Life scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.